Literature DB >> 16698746

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

J Satsangi1, M S Silverberg, S Vermeire, J-F Colombel.   

Abstract

In recent years, investigators have readdressed the complex issues involved in the classification of inflammatory bowel diseases. In 2003, a Working Party of investigators with an interest in the issues involved in disease subclassification was formed with the aim of summarising recent developments in disease classification and establishing an integrated clinical, molecular, and serological classification of inflammatory bowel disease. The results of the Working Party were reported at the 2005 Montreal World Congress of Gastroenterology. Here we highlight the key issues that have emerged from discussions of the Montreal Working Party and the relevance to clinical practice and research activities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698746      PMCID: PMC1856208          DOI: 10.1136/gut.2005.082909

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  The value of serologic markers in indeterminate colitis: a prospective follow-up study.

Authors:  Sofie Joossens; Walter Reinisch; Séverine Vermeire; Boualem Sendid; Daniel Poulain; Marc Peeters; Karel Geboes; Xavier Bossuyt; Peggy Vandewalle; Georg Oberhuber; Harald Vogelsang; Paul Rutgeerts; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

2.  A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.

Authors:  C Gasche; J Scholmerich; J Brynskov; G D'Haens; S B Hanauer; E J Irvine; D P Jewell; D Rachmilewitz; D B Sachar; W J Sandborn; L R Sutherland
Journal:  Inflamm Bowel Dis       Date:  2000-02       Impact factor: 5.325

3.  Association of NOD2 with Crohn's disease in a homogenous Irish population.

Authors:  Emer Bairead; Dawn L Harmon; Anne M Curtis; Yvette Kelly; Clare O'Leary; Michelle Gardner; Dermot T Leahy; Pat Vaughan; Denise Keegan; Colm O'Morain; Diarmuid O'Donoghue; Fergus Shanahan; Nollaig A Parfrey; Kathleen A Quane
Journal:  Eur J Hum Genet       Date:  2003-03       Impact factor: 4.246

4.  Course of ulcerative colitis: analysis of changes in disease activity over years.

Authors:  E Langholz; P Munkholm; M Davidsen; V Binder
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

5.  Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'.

Authors:  A B Price
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

6.  Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.

Authors:  Ian D R Arnott; Carol J Landers; Elaine J Nimmo; Hazel E Drummond; Ben K R Smith; Stephan R Targan; Jack Satsangi
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

7.  Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Authors:  Nagamu Inoue; Kazuo Tamura; Yoshitaka Kinouchi; Yoshihiro Fukuda; Seiichi Takahashi; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez; Yusuke Kishi; Yuji Koike; Tooru Shimosegawa; Takashi Shimoyama; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

8.  NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?

Authors:  I D R Arnott; E R Nimmo; H E Drummond; J Fennell; B R K Smith; E MacKinlay; J Morecroft; N Anderson; D Kelleher; M O'Sullivan; R McManus; J Satsangi
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

9.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.

Authors:  William S Mow; Eric A Vasiliauskas; Ying-Chao Lin; Phillip R Fleshner; Konstantinos A Papadakis; Kent D Taylor; Carol J Landers; Maria T Abreu-Martin; Jerome I Rotter; Huiying Yang; Stephan R Targan
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

10.  Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease.

Authors:  Maria T Abreu; Kent D Taylor; Ying-Chao Lin; Tieu Hang; Joanne Gaiennie; Carol J Landers; Eric A Vasiliauskas; Lori Y Kam; Micha Rojany; Konstantinos A Papadakis; Jerome I Rotter; Stephan R Targan; Huiying Yang
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

View more
  783 in total

1.  Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.

Authors:  Daniéla Oliveira Magro; Everton Cazzo; Paulo Gustavo Kotze; Ana Carolina Junqueira Vasques; Carlos Augusto Real Martinez; Elinton Adami Chaim; Bruno Geloneze; José Carlos Pareja; Cláudio Saddy Rodrigues Coy
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

2.  Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.

Authors:  Zhaoxia Zhang; Chen Li; Xinmei Zhao; Chaolan Lv; Qiong He; Shan Lei; Yandong Guo; Fachao Zhi
Journal:  Dig Dis Sci       Date:  2012-06-06       Impact factor: 3.199

3.  Serial intralesional injections of infliximab in small bowel Crohn's strictures are feasible and might lower inflammation.

Authors:  Jakob Hendel; John Gásdal Karstensen; Peter Vilmann
Journal:  United European Gastroenterol J       Date:  2014-10       Impact factor: 4.623

4.  Dynamic pathology for circulating free DNA in a dextran sodium sulfate colitis mouse model.

Authors:  Yuhki Koike; Keiichi Uchida; Koji Tanaka; Shozo Ide; Kohei Otake; Yoshiki Okita; Mikihiro Inoue; Toshimitsu Araki; Akira Mizoguchi; Masato Kusunoki
Journal:  Pediatr Surg Int       Date:  2014-11-04       Impact factor: 1.827

5.  Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.

Authors:  Sara Lewin; Fernando S Velayos
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-09

6.  Serum antibodies and anthropometric data at diagnosis in pediatric Crohn's disease.

Authors:  Anna K Trauernicht; Steven J Steiner
Journal:  Dig Dis Sci       Date:  2011-11-11       Impact factor: 3.199

7.  Association of age at diagnosis and ulcerative colitis phenotype.

Authors:  Sandra M Quezada; Raymond K Cross
Journal:  Dig Dis Sci       Date:  2012-02-28       Impact factor: 3.199

8.  Genotype/Phenotype correlations in inflammatory bowel disease.

Authors:  Laura E Harrell
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-07

9.  PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine.

Authors:  Chandan Jyoti Das; Govind Makharia; Rakesh Kumar; Madhavi Chawla; Pooja Goswami; Raju Sharma; Arun Malhotra
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-21       Impact factor: 9.236

10.  Relapse Prevention by Plant-Based Diet Incorporated into Induction Therapy for Ulcerative Colitis: A Single-Group Trial.

Authors:  Mitsuro Chiba; Kunio Nakane; Tsuyotoshi Tsuji; Satoko Tsuda; Hajime Ishii; Hideo Ohno; Kenta Watanabe; Yu Obara; Masafumi Komatsu; Takeshi Sugawara
Journal:  Perm J       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.